Biomarkers of Chinese advanced cancer patients based on real-world data: Actionable genomic alterations and tumor mutational burden.

被引：0
|
作者：
Wang, HaiTao
Wang, Huina
Guo, Rongyun
Li, Mingwei
Zhang, Yanrui
Lou, Feng
Cao, Shanbo
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14280
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-world genomic testing patterns in patients with prostate cancer
    Kaakou, Dalia
    Mar, Nataliya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 97 - 97
  • [32] Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer
    Shi, Jie
    Wang, Zhiyu
    Zhang, Junping
    Xu, Yaping
    Xiao, Xiao
    Quan, Xiangming
    Bai, Ying
    Yang, Xia
    Ming, Zongjuan
    Guo, Xiaojin
    Feng, Huijing
    Yang, Xiaoling
    Zhuang, Xiaofei
    Han, Fei
    Wang, Kai
    Shi, Yonglei
    Lei, Yu
    Bai, Jun
    Yang, Shuanying
    CLINICAL CANCER RESEARCH, 2021, 27 (22) : 6184 - 6196
  • [33] Distribution of actionable genetic variants in different sample types of Chinese NSCLC: A large real-world data based study
    Lin, D.
    Wu, C.
    Feng, Q.
    Wu, W.
    Wang, Y.
    Dong, Z.
    Lian, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S867 - S868
  • [34] Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis
    Mennini, F. S.
    Marcellusi, A.
    Sciattella, P.
    Scortichini, M.
    Ragonese, Angela
    Cattel, F.
    D'Antona, R.
    Del Mastro, L.
    Gori, S.
    Perrone, G.
    Migliorini, R.
    Trabucco Aurilio, M.
    PHARMACOECONOMICS-OPEN, 2025, 9 (02) : 283 - 290
  • [35] Penile squamous cell carcinoma with high and very high tumor mutational burden (TMB): A genomic landscape and "real-world" clinical outcome study
    Jacob, J. M.
    Spiess, P.
    Padua, T. C. D.
    Li, R.
    Grivas, P.
    Huang, R.
    Lin, D. I.
    Danziger, N. A.
    Ross, J. S.
    Li, G.
    Graf, R. P.
    Pavlick, D. C.
    Basnet, A.
    Bratslavsky, G.
    Necchi, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S506 - S506
  • [36] Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
    Palmeri, M.
    Mehnert, J.
    Silk, A. W.
    Jabbour, S. K.
    Ganesan, S.
    Popli, P.
    Riedlinger, G.
    Stephenson, R.
    de Meritens, A. B.
    Leiser, A.
    Mayer, T.
    Chan, N.
    Spencer, K.
    Girda, E.
    Malhotra, J.
    Chan, T.
    Subbiah, V
    Groisberg, R.
    ESMO OPEN, 2022, 7 (01)
  • [37] Microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) as predictive biomarkers for immune checkpoint inhibitor (ICI) effectiveness in real-world patients with metastatic colorectal cancer (mCRC).
    Ellis, Haley
    Klempner, Samuel J.
    Quintanilha, Julia C. F. C. F.
    Myer, Parvathi
    Lin, Douglas I.
    Panarelli, Nicole
    Fisher, Virginia
    Li, Gerald
    Huang, Richard S. P.
    Ross, Jeffrey S.
    Oxnard, Geoffrey R.
    Graf, Ryon
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 46 - 46
  • [38] Assessment of the use of real-world data to support a study in patients with advanced cancer and cachexia
    Bosan, Rafia
    Wells, Karen E.
    Chessari, Salvatore
    Rotaru, Daniela D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 239 - 239
  • [39] Correlation among actionable gene mutations, microsatellite instability and tumor mutational burden in advanced colorectal cancer and association with survival
    Miyashita, Hirotaka
    Brooks, Gabriel
    Kurzrock, Razelle
    Kato, Shumei
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Genomic characterization of thymic epithelial tumor from real-world data.
    Kurokawa, Kana
    Shukuya, Takehito
    Greenstein, Ray
    Kaplan, Benjamin G.
    Wakelee, Heather A.
    Miura, Keita
    Furuta, Kazuyuki
    Suh, Junghee
    Sokol, Ethan
    Carbone, David Paul
    Takahashi, Kazuhisa
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345